Sons, an Irish start-up providing hair loss treatments for men, has secured €6.75 million in funding through debt and equity investment.
WHO: Founded in 2000 by Adrian Gilbane and Will Kennedy, Sons aims to bring men’s health and well-being into the 21st century. Less stigma, clearer information, more convenience, better results. The company has developed a range of clinically proven hair loss treatments for men backed by medical experts, including its Medical Director Knut Moe, who has experience with leading hair restoration clinic Hair Restoration Blackrock (HRBR). Sons products are available at Boots, Boots Ireland stores nationwide, and Amazon, as well as through distributors such as Uniphar and United Drug.
WHY: The funding will be used to scale its operations across Europe.
IN THEIR OWN WORDS: “We are committed to challenging norms and encouraging men to prioritize their health. Driven by in-depth scientific research, our range of products is reshaping the arenas of hair loss and other stigmatized conditions like dandruff,” founder and CEO Will Kennedy told Business Post. “With the introduction of every new product, we are challenging the possibilities of what can be achieved.”
“We are delighted to be supporting Sons’ ambitious growth plans. We have been hugely impressed by Will, Adrian, and the wider team, and the success achieved to date,” Sinead Heaney, Manager of the Davy EIIS Funds, said.
DETAILS:
